Cargando…

The definition of tuberculosis infection based on the spectrum of tuberculosis disease

Latent tuberculosis infection was the term traditionally used to indicate tuberculosis (TB) infection. This term was used to define “a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens through tests such as the tuberculin skin test (TST) or an interferon-γ rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Migliori, Giovanni Battista, Ong, Catherine W.M., Petrone, Linda, D'Ambrosio, Lia, Centis, Rosella, Goletti, Delia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753649/ https://www.ncbi.nlm.nih.gov/pubmed/35035549 http://dx.doi.org/10.1183/20734735.0079-2021

Ejemplares similares

New anti-tuberculosis drugs and regimens: 2015 update
por: D'Ambrosio, Lia, et al.
Publicado: (2015)

A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European Respiratory Society-World Health Organization tuberculosis Consilium
por: D’Ambrosio, Lia, et al.
Publicado: (2017)

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis
por: Migliori, Giovanni Battista, et al.
Publicado: (2019)

Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey
por: Amicosante, Massimo, et al.
Publicado: (2017)

Recent developments in the diagnosis and management of tuberculosis
por: Sulis, Giorgia, et al.
Publicado: (2016)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study
por: Nalunjogi, Joanitah, et al.
Publicado: (2023)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones
por: Migliori, Giovanni Battista, et al.
Publicado: (2012)

Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
por: García-García, José-María, et al.
Publicado: (2022)

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?
por: Muñoz-Torrico, Marcela, et al.
Publicado: (2016)

The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2023)

Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs
por: Pontali, Emanuele, et al.
Publicado: (2022)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
por: Arbex, Marcos Abdo, et al.
Publicado: (2015)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
por: Maryandyshev, Andrey, et al.
Publicado: (2017)

Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects
por: Visca, D., et al.
Publicado: (2021)

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
por: Petrone, Linda, et al.
Publicado: (2021)

Eliminating tuberculosis in Latin America: making it the point
por: Duarte, Raquel, et al.
Publicado: (2018)

The battle against colistin-resistant E. coli and the need for a one health approach
por: Danaei, Bardia, et al.
Publicado: (2023)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)
por: Ong, Catherine Wei Min, et al.
Publicado: (2020)

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
por: Petruccioli, Elisa, et al.
Publicado: (2016)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023)

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
por: Tadolini, Marina, et al.
Publicado: (2016)

Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
por: Cantini, Fabrizio, et al.
Publicado: (2017)

Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children
por: Petrone, Linda, et al.
Publicado: (2015)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

Tuberculosis series 2020
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gejarea8qu4r3r7bu096pi22hh